Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula Patency

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):754-764. doi: 10.1161/ATVBAHA.119.312417.

Abstract

Objective- Arteriovenous fistulae (AVF) are the most common access created for hemodialysis; however, many AVF fail to mature and require repeated intervention, suggesting a need to improve AVF maturation. Eph-B4 (ephrin type-B receptor 4) is the embryonic venous determinant that is functional in adult veins and can regulate AVF maturation. Cav-1 (caveolin-1) is the major scaffolding protein of caveolae-a distinct microdomain that serves as a mechanosensor at the endothelial cell membrane. We hypothesized that Cav-1 function is critical for Eph-B4-mediated AVF maturation. Approach and Results- In a mouse aortocaval fistula model, both Cav-1 mRNA and protein were increased in the AVF compared with control veins. Cav-1 KO (knockout) mice showed increased fistula wall thickening ( P=0.0005) and outward remodeling ( P<0.0001), with increased eNOS (endothelial NO synthase) activity compared with WT (wild type) mice. Ephrin-B2/Fc inhibited AVF outward remodeling in WT mice but not in Cav-1 KO mice and was maintained in Cav-1 RC (Cav-1 endothelial reconstituted) mice (WT, P=0.0001; Cav-1 KO, P=0.7552; Cav-1 RC, P=0.0002). Cavtratin-a Cav-1 scaffolding domain peptide-decreased AVF wall thickness in WT mice and in Eph-B4 het mice compared with vehicle alone (WT, P=0.0235; Eph-B4 het, P=0.0431); cavtratin also increased AVF patency (day 42) in WT mice ( P=0.0275). Conclusions- Endothelial Cav-1 mediates Eph-B4-mediated AVF maturation. The Eph-B4-Cav-1 axis regulates adaptive remodeling during venous adaptation to the fistula environment. Manipulation of Cav-1 function may be a translational strategy to enhance AVF patency.

Keywords: arteriovenous fistula; caveolin-1; endothelial cells; mice; veins.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Aorta, Abdominal / surgery
  • Arteriovenous Shunt, Surgical*
  • Caveolae / metabolism
  • Caveolin 1 / biosynthesis
  • Caveolin 1 / deficiency
  • Caveolin 1 / genetics
  • Caveolin 1 / pharmacology
  • Caveolin 1 / physiology*
  • Cells, Cultured
  • Drug Evaluation, Preclinical
  • Hemorheology
  • Humans
  • Lung / cytology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Nitric Oxide Synthase Type III / physiology
  • Peptide Fragments / pharmacology
  • Receptor, EphB4 / physiology*
  • Signal Transduction / physiology*
  • Vascular Remodeling / physiology
  • Vena Cava, Inferior / physiology*
  • Vena Cava, Inferior / surgery

Substances

  • CAV1 protein, human
  • Cav1 protein, mouse
  • Caveolin 1
  • Peptide Fragments
  • caveolin-1 (82-101)
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Ephb4 protein, mouse
  • Receptor, EphB4